Press/Media items

A paradigm shift in neuropsychiatry

Press/Media: ResearchAcademic


New approaches to advancing drug development for the treatment of neuropsychiatric disorders will be outlined in this afternoon’s joint ECNP-EPA symposium. The session will look at the applications of neuroimag-ing in this area, as well as novel methods for investigating drug effects using human models of emotional processing.
Martien Kas, Professor of Behavioural Neuroscience at the University of Groningen (the Netherlands) will talk about the latest work of a major EU project he coordinates, the Psychiatric Ratings using Intermediate Stratified Markers (PRISM) project.


Related Activities
  1. Moving towards an integrated approach for psychiatric research

    Martien Kas (Invited speaker)

    Activity: Talk or presentationAcademic

View all (1) »

ID: 55377571